Cargando…
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment
Dose–response curves for headaches relief and adverse events (AEs) are presented for five triptans: sumatriptan, zolmitriptan, naratriptan, almotriptan, and frovatriptan, and the CGRP antagonist telcagepant. The upper part of the efficacy curve of the triptans is generally flat, the so-called ceilin...
Autor principal: | Tfelt-Hansen, Peer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094671/ https://www.ncbi.nlm.nih.gov/pubmed/21350792 http://dx.doi.org/10.1007/s10194-011-0309-5 |
Ejemplares similares
-
Success and failure of triptans
por: Saxena, Pramod R., et al.
Publicado: (2001) -
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
por: Tfelt-Hansen, Peer
Publicado: (2007) -
Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis☆
por: Yao, Gang, et al.
Publicado: (2013) -
The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects
por: Han, Tae H, et al.
Publicado: (2010) -
Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
por: Kogelman, Lisette J. A., et al.
Publicado: (2023)